Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease.
about
Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune DiseasesReasons to Investigate the Soluble Receptor for Advanced Glycation End-Product (sRAGE) Pathway in Aortic Disease.Predictive value of red blood cell distribution width for coronary artery lesions in patients with Kawasaki disease.S100A12 expression in patients with primary biliary cirrhosis.Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.Carnosine Supplementation Improves Serum Resistin Concentrations in Overweight or Obese Otherwise Healthy Adults: A Pilot Randomized Trial
P2860
Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Reverse regulation of soluble ...... d S100A12 in Kawasaki disease.
@en
type
label
Reverse regulation of soluble ...... d S100A12 in Kawasaki disease.
@en
prefLabel
Reverse regulation of soluble ...... d S100A12 in Kawasaki disease.
@en
P2093
P2860
P356
P1476
Reverse regulation of soluble ...... d S100A12 in Kawasaki disease.
@en
P2093
Chunhong Xie
Fangqi Gong
Qing Zhang
Songling Fu
P2860
P2888
P356
10.1186/AR4094
P577
2012-11-21T00:00:00Z
P5875
P6179
1036215054